U.S. General Merchandise and Department Stores Stock News

If you have been following Ross Stores (ROST), the recent stretch of share price volatility might have you pausing to rethink your next move. While there has not been a headline-grabbing announcement, the stock’s month-long gain of 7% stands out following a year of more mixed results. This unusual momentum in the absence of big news has caught the eye of many investors who are trying to make sense of what might be driving the uptick. Looking at the bigger picture, Ross Stores had a fairly...

Vanguard Index Funds: Vanguard S&P 500 ETF (VOO) has quietly moved onto the radar of investors once again, with recent price swings raising a few eyebrows. There is no major headline or single market-moving event driving these price changes. However, the shift is catching attention, as it comes amid an ongoing debate about the state of the broader market. When VOO sees a swing, whether small or large, it often sparks a discussion about value, risk, and timing, given its role as a bellwether...

If you have been eyeing Dollar General stock and wondering if now is the right time to buy, sell, or simply hold, you are not alone. After all, Dollar General has been on quite the ride lately, keeping investors on their toes. Over the past 90 days, shares are up more than 10%, signaling renewed optimism after a rocky year, even though the 1-year total return is still in the red at around -6%. That turnaround story, mixed with cautious excitement, seems to be the theme at play for Dollar...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

In its most recent quarterly results, Coterra Energy reported strong free cash flow and production growth, overcoming lower commodity prices and operational hurdles in the Harkey wells. This performance was largely attributed to effective cost controls, robust hedging, and supportive natural gas storage and supply conditions that strengthen the company's gas-weighted portfolio ahead of winter. We'll examine how Coterra Energy's operational resilience and strong cash generation may influence...

If you have been eyeing Home Depot stock lately, you are not alone. Plenty of investors are weighing what to do after seeing the company's shares climb over 11% this past year and more than 55% in five years. The biggest home improvement retailer in the US has shown real resilience, especially with a steady flow of headlines and rumors about deals, including a recent buzz over its bid for GMS Inc. Even after a short-lived dip earlier in the year, Home Depot’s quick recovery signals that Wall...

If you are watching CAVA Group's stock and feeling torn over your next move, you are definitely not alone. The past year has been a wild ride, with CAVA's share price swinging notably over both the short and long term. In just the last month, the stock has slipped about 25%, and year-to-date it is down over 41%. That kind of volatility always catches the eye, especially for a company like CAVA, which has posted steady annual revenue growth of around 17% and net income growth close to...

Earlier this week, Charles River Associates (CRA) announced the appointment of Chris Rucinski as Vice President to expand its Forensic Services Practice, adding significant expertise in intellectual property and technology disputes. This addition reflects CRA's intent to enhance its ability to address complex software and hardware analyses for clients facing high-stakes litigation and technical challenges. We'll explore how enhanced forensic expertise supports CRA's investment story by...

3M (MMM) is once again drawing interest after its latest quarterly results topped Wall Street expectations, sending the stock up in recent trading sessions. The company’s net income climbed in part due to a turnaround in its healthcare business and recovery in industrial demand. Both of these factors play a significant role in 3M’s long-term narrative. For shareholders who have been waiting for clearer signs of progress, this earnings beat represents a shift from the uncertainty that has...

Unfortunately for some shareholders, the Kaltura, Inc. ( NASDAQ:KLTR ) share price has dived 27% in the last thirty...

Investors in Sarepta Therapeutics (SRPT) have likely noticed the stock’s pronounced swings recently, with a sharp drop in the past year now giving way to a month of strong gains. There has not been any major breaking event or market-moving update to explain this renewed enthusiasm, which makes the sudden change in sentiment all the more intriguing. For those holding SRPT or considering an entry, this move might feel like a signal, though it is not clear yet whether it represents sustainable...

Life Time Group Holdings (LTH) just rolled out LTH Dream, a magnesium-based, melatonin-free sleep support powder. This new product fits right in with Life Time’s push to offer wellness solutions that address real consumer concerns, in this case, better sleep without side effects. It lands alongside another sign of growth, as Life Time opens a sleek new athletic country club in Atlanta that caters to health-focused professionals and families looking for community, fitness, and recovery, all...

If you have been watching Baidu’s stock lately, you are not alone. Investors everywhere are debating whether it is time to pounce, hold tight, or look elsewhere. Baidu’s share price has been on a bit of a journey, rising 0.9% over the past day but showing slight declines over the past week and month. The picture starts to shift if you zoom out. Despite modest year-to-date gains of around 6%, much longer-term returns have been tougher, with three- and five-year results still in the red. But...

So, you are keeping an eye on Cummins stock and wondering whether it should find a place in your portfolio, or if it is time to lock in gains. You are not alone. Cummins has caught plenty of attention lately, both for its steady performance and for the market noise swirling around industrial names. In just the past year, the stock has soared roughly 32% higher, a move that has left some investors impressed and others hesitant, asking whether the run can continue. The most recent momentum is...

If you are considering what to do with HCA Healthcare stock right now, you are not alone. The stock has sparked plenty of interest lately, and for good reason, as its recent price movements have left investors debating whether to buy, sell, or simply hold tight. Over just the past month, HCA shares have soared by more than 15%, and year-to-date the stock is up a striking 35.8%. This momentum stands out in the healthcare sector. Longer-term gains are also notable, with HCA delivering a total...

Fastenal (FAST) shares have caught the eye of many investors lately, not because of a headline-grabbing event, but thanks to a steady climb in the stock price that invites a closer look. Sometimes, it is these quieter stretches that prompt the important question: Are we overlooking something in the company’s fundamentals, or is the current momentum a signal worth listening to? Fastenal’s business may seem straightforward as a major distributor of fasteners and industrial supplies, but in...

Stride, Inc. ( NYSE:LRN ) shareholders would be excited to see that the share price has had a great month, posting a...

Trying to figure out what to do with F5 stock? You are not alone. Whether you are watching the ticker for a potential entry point or wondering whether to let your gains run, F5 has become a talking point for investors this year. The stock has climbed sharply, posting a 24.8% year-to-date return and a notable 60.5% gain over the past 12 months. This consistent upward trend, especially over longer timeframes, often leads investors to ask: is it too late to buy in, or could there be more room to...

If you are wondering what to do with Steel Dynamics stock right now, you are not alone. In a market full of headlines and volatility, this company has been turning heads, especially after some notable policy changes shook up the global steel trade. Over the past year, shares of Steel Dynamics have gained nearly 7.4%. While this may not appear spectacular at first glance, the real story emerges when you take a longer view. Over five years, the stock has delivered a 361% total return for...

Are you on the fence about Snowflake, trying to figure out whether it is the right moment to buy, hold, or cash out? You are not alone, and the market has not made the answer easy. Over the past year, the stock has swung dramatically. It is up almost 69% in the past 12 months, yet it dipped more than 8% in the past 30 days and is just about flat over the last three months. These moves come at a time when Snowflake continues to deliver double-digit annual revenue growth, but remains...

If you are watching Kroger and wondering whether now is the right moment to buy, hold, or take some profits, you are not alone. The company’s stock has been grabbing attention thanks to some impressive moves lately. Over the past year, shares have soared nearly 40%, easily outpacing broader market indexes. Even looking further back, the 3-year total return stands at just over 54%, and in the last five years, shareholders have more than doubled their investment. So, what’s behind this steady...

Thinking about what to do with LyondellBasell Industries stock? You are not alone. Whether you have been following this chemical giant for years or just started eyeing it on the NYSE, there is a lot to consider right now. Shares have jolted up nearly 4% over the past week as broader market sentiment brightened, despite LYB sliding more than 15% in the past month. This recent pop is a reminder that, even with a choppy year behind it, investor interest can return quickly, especially if risk...

If you’ve been keeping an eye on Old Dominion Freight Line stock lately, you’re probably wondering whether now’s the moment to jump in, double down, or hold your ground. It’s been a bumpy ride over the past year, with the share price sliding nearly 25% in the last twelve months. Even zooming out to the last three months shows a dip of about 7%. Looking further back, however, reveals hints of long-term growth, as the stock is actually up more than 53% over five years. Why the recent downturn?...

Earlier this month, Soleno Therapeutics came under scrutiny after a critical Scorpion Capital report raised concerns about the safety of its drug VYKAT™ XR and questioned clinical trial data integrity. The resulting investigations by multiple law firms have amplified doubts over the company's regulatory and commercial pathway for its lead therapy. We'll take a closer look at how questions about VYKAT™ XR's trial data are shaping the investment narrative for Soleno Therapeutics. The end of...